CREYON BIO
Creyon Bio is a pre-clinical stage company reimagining drug development as it should be, using a data-first approach for generating uniquely powerful datasets and developing machine learning models to uncover the engineering principles that make precision oligonucleotide-based medicines possible for patient populations of all sizes.
CREYON BIO
Industry:
Biotechnology Life Science
Founded:
2019-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.creyonbio.com
Status:
Active
Total Funding:
40 M USD
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
XinThera
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
Current Advisors List
Board_member
2022-03-01
Board_member
2022-03-01
Board_member
2022-03-01
Current Employees Featured
Christopher Hart Co-Founder & CEO @ Creyon Bio
Co-Founder & CEO
Monica McArthur Chief Technology Officer @ Creyon Bio
Chief Technology Officer
David Dimmock Chief Medical Officer @ Creyon Bio
Chief Medical Officer
2022-02-01
Nathan Billings Chief Strategy Officer @ Creyon Bio
Chief Strategy Officer
Swagatam Mukhopadhyay Chief Scientific Officer & Co-founder @ Creyon Bio
Chief Scientific Officer & Co-founder
Founder
Investors List
DCVC Bio
DCVC Bio investment in Series A - Creyon Bio
BioBrit
BioBrit investment in Series A - Creyon Bio
Lux Capital
Lux Capital investment in Series A - Creyon Bio
Casdin Capital
Casdin Capital investment in Series A - Creyon Bio
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Creyon Bio
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-24 | David Dimmock, M.D., Joins Creyon Bio as Chief Medical Officer |
Official Site Inspections
http://www.creyonbio.com
- Host name: 222.253.160.34.bc.googleusercontent.com
- IP address: 34.160.253.222
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Creyon Bio"
Our Team - Creyon Bio
He is Co-Founder and President of the Castleman Disease Collaborative Network (CDCN), a non-profit organization dedicated to accelerating research and treatment for Castleman disease …See details»
Creyon Bio - Crunchbase Company Profile & Funding
Contact Email info@creyonbio.com Creyon Bio is a pre-clinical stage company reimagining drug development as it should be, using a data-first approach for …See details»
Creyon Bio - LinkedIn
Creyon Bio is thrilled to announce a global licensing and multi-target research collaboration with Eli Lilly and Company to discover, develop, and commercialize a new generation of RNA-targeted ...See details»
Our Work - Creyon Bio
Creyon is excited to partner with disease organizations and patient advocacy groups to set up pilot projects, build out processes for responding quickly to a disease diagnosis and rapidly …See details»
Creyon 2025 Company Profile: Valuation, Funding
Apr 3, 2020 Creyon General Information Description. Developer of drugs designed to engineer RNA-based medicines and their components. The company creates proprietary, purpose-built datasets that inform powerful machine …See details»
CREYON BIO, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CREYON BIO, INC. of Carlsbad, CA. Get the latest business insights from Dun & Bradstreet.See details»
Creyon Bio - Org Chart, Teams, Culture & Jobs - The Org
View Creyon Bio's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Creyon Bio - Products, Competitors, Financials, Employees, …
Creyonbio.com. Overview & Products; Financials; People; Founded Year 2019. Stage Series A | Alive. Total Raised $40M. Last Raised $35M | 3 yrs ago. About Creyon Bio. Creyon Bio is a …See details»
Creyon Bio - Craft
Creyon Bio is a reinventing drug development company that develops oligonucleotide-based medicines (OBMs). It creates gene-centric therapies and drug modalities such as small …See details»
Creyon Bio - Overview, News & Similar companies | ZoomInfo.com
May 1, 2024 www.creyonbio.com. Revenue $5.5 Million. Industry Business Services General Business Services . Recent News & Media. Creyon Bio to Present Clinical Data on Rapid AI …See details»
Creyon Bio Expands Senior Leadership Team with Two Appointments
Jul 20, 2023 Company Announces Chief Operating Officer & General Counsel Jason Ferrone, JD, and Chief Financial Officer Robert Muir. SAN DIEGO and RESEARCH TRIANGLE PARK, …See details»
Contact Us - Creyon Bio
Creyon Bio is eager to partner with like-minded researchers, clinicians, and patient advocacy groups to advance their vision. Get in touch via the email below to inquire about positions, …See details»
Creyon debuts to disrupt oligonucleotide research
Mar 21, 2022 Creyon Bio, an oligonucleotide research specialist with the goal of designing precision medicines, has emerged with $40 million from a series A financing round led by …See details»
Chris Hart’s Post - LinkedIn
Chris, it's been an amazing ride, we have got to do some amazing things. Thanks for making this all happen and mentoring me along the way. Here is to the next adventureSee details»
Creyon Bio - Company info. interviews, news - BiopharmaTrend
Jan 26, 2024 Creyon Bio is a pre-clinical stage company reimagining drug development as it should be, using a data-first approach for generating uniquely powerful datasets and …See details»
Creyon Bio is Creating Precision Medicines for Diseases ... - BioSpace
Mar 8, 2022 Creyon Bio CEO Chris Hart and CSO Swagatam Mukhopadhyay/courtesy Creyon Bio. Creyon Bio, a San Diego and North Carolina-based drug development company, …See details»
Creyon Bio and Lilly Enter into RNA-Targeted Oligo Therapy …
Apr 29, 2025 Media Nina Gill LaVoieHealthScience 781-856-3103 creyonbio@lavoiehealthscience.com. Social Media Profiles. Creyon Bio LinkedIn . Creyon Bio …See details»
Creyon Bio | North Carolina Biotech Center
Creyon Bio is a drug development company engineering RNA-based medicines and their components.See details»
Creyon Bio Launches to Engineer Safe, Effective Precision
Mar 8, 2022 Creyon Bio, Inc., a drug development company engineering RNA-based medicines and their components with predictable safety and efficacy profiles, launched with the goal of …See details»
Creyon Bio Launches to Engineer Safe, Effective Precision …
Mar 8, 2022 Creyon's drug development platform creates purpose-built data sets orders of magnitude more efficient than current approaches, Proprietary machine learning models …See details»